Sign In
Buy EYPT
$12.25
-0.610 (-4.74%)
At Close: Jul 31, 2026
EyePoint Pharmaceuticals Reports Second Quarter 2020 Financial Results and Highlights Recent Corporate Developments
11:00am, Wednesday, 05'th Aug 2020
\- Total revenues of $4.1 million and net product revenues of $3.7 million impacted by COVID-19 pandemic - \- U.S. commercial alliance with ImprimisRx to expand reach of DEXYCU® -\- Jay S. Duker,
The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings
12:00am, Wednesday, 05'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 4)
ABIOMED, Inc. (NASDAQ: ABMD) (FDA approved the emergency use of Abiomed's Impella heart pump in combination...
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
EyePoint Pharmaceuticals Announces Second Quarter 2020 Financial Results Release Date and Conference Call Information
11:00am, Wednesday, 29'th Jul 2020
WATERTOWN, Mass., July 29, 2020 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products,
WATERTOWN, Mass., July 27, 2020 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products,
\- World-renowned retina specialist to lead EYP-1901 development efforts and support expansion of EyePoint’s ocular disease pipeline - WATERTOWN, Mass., July 13, 2020 --.
Outlook of Diabetic Macular Edema (DME) 2020-2025 - Current Landscape and the Way Forward - ResearchAndMarkets.com
12:00am, Monday, 13'th Jul 2020
The
Top Stocks To Short As Dow Jumps Amid Coronavirus Spikes
12:00am, Monday, 06'th Jul 2020
Despite valuations looking expensive, the markets are in a good place as of this morning, despite the cases for coronavirus spiking over the weekend. Some may say the market is getting ahead of itself
EyePoint Pharmaceuticals, Inc.'s (NASDAQ:EYPT) Profit Outlook
11:59am, Thursday, 02'nd Jul 2020
EyePoint Pharmaceuticals, Inc.'s (NASDAQ:EYPT): EyePoint Pharmaceuticals, Inc., a specialty biopharmaceutical company...
H.C. Wainwright Initiates a Buy Rating on Applied DNA Sciences (APDN) - Markets
10:07am, Thursday, 02'nd Jul 2020
In a report released today, Yi Chen from H.C. Wainwright initiated coverage with a Buy rating on Applied DNA Sciences
2020 Study into the Global Macular Edema Industry - Market Size and Drug Sales - ResearchAndMarkets.com
12:00am, Thursday, 02'nd Jul 2020
The
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ObsEva SA
B.Riley FBR Keeps a Buy Rating on Intricon (IIN) - Markets
11:20am, Friday, 26'th Jun 2020
In a report released yesterday, Andrew D’silva from B.Riley FBR maintained a Buy rating on Intricon (IIN – Research Report),
Stocks To Hedge Your Portfolio With Amid Rising Coronavirus Cases
12:00am, Thursday, 25'th Jun 2020
If you’re looking to hedge against a coming pullback in the markets, we've used our deep learning algorithms and AI to identify the Top Shorts today.
